Status:
COMPLETED
Omega-3 Supplementation After Surgical Treatment of Obesity
Lead Sponsor:
Instituto de Cardiologia do Rio Grande do Sul
Conditions:
Obesity
Eligibility:
All Genders
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The study evaluates diet supplementation of Omega-3 fatty acids after surgical treatment of obesity in adults. Half participants will receive diet supplementation of Omega-3 fatty acids, while the oth...
Detailed Description
Omega-3 fatty acids has been related to immunomodulation and antioxidant action. Diet supplementation of Omega-3 fatty acids after surgical treatment of obesity may help stabilize protein catabolism, ...
Eligibility Criteria
Inclusion
- BMI \> 30kg/m2
- Candidate to bariatric and metabolic surgery
Exclusion
- Use of Omega-3
- Contraindication to bioimpedance analysis
- Uso of steroids, non steroidal inflammatory drugs, immunomodulators or antibiotics
- Refusal to participate
Key Trial Info
Start Date :
April 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 4 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06494566
Start Date
April 10 2019
End Date
December 4 2023
Last Update
July 10 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Irmandade Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, Rio Grande do Sul, Brazil, 90035-072
2
Instituto de Cardiologia
Porto Alegre, Rio Grande do Sul, Brazil, 90040-371